ESTRO Vision 2030.
"Radiation Oncology. Optimal Health for all, together."
If, by 2035, every cancer patient who needs radiotherapy has access to it, almost one million more lives will be saved every year worldwide.
The ESTRO membership 2021 is now open.
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy - Read It
17th St. Gallen International Breast Cancer Conference - Conferences Corner
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomised Phase III Trial: The DBCG HYPO Trial - Read It
Report on the 6th European Particle Therapy Network workshop - Research Corner
Image-Guided and Adaptive Radiotherapy - School Corner